On Chemball
My Chemball
+86-571-8627 3270
Yuanshu Pharmaceutical Technology Co., Ltd.
Yuanshu Pharmaceutical Technology Co., Ltd.
9 YRS
Jiangsu, China
Main Products:
Anthrone / Dithranol / Emodin Anthrone / Hypericin / Itopride Hydrochloride / 2-[2-(3-Methoxyphenyl)Ethyl]Phenol / 6-Aminomethyl-5,6-Dihydromorphanthridine / 4-(4-Phenylbutoxy)Benzoic Acid / 4-Phenyl-1-Butyl Bromide / 5-(4-Chlorobutyl)-1-Cyclohexyl-1H-Tetrazole / 6-Hydroxy-2(1H)-3,4-Dihydroquinolinone / 3-Aminopyrrolidine Dihydrochloride / Ethyl 1-(2,4-Difluorophenyl)-7-Choro-6-Fluoro-4-Oxo-Hydropyridino[2,3-B] Pyridine-3-Carboxylate / 7,10-Dichloro-2-Methoxybenzo[b]-1,5-Naphthyridine / 4-Amino-2,6-bis(Pyrrolidin-1-Ylmethyl)Phenol
Jiangsu, China
Send Email
Sending...
Thank You！
Your requirement has been sent, we will contact you quickly!
Sent Failed！
Try again!
Anthrone
Dithranol
Emodin Anthrone
Hypericin
Itopride Hydrochloride
Sarpogrelate Hydrochloride Intermediate
Epinastine Intermediate
Pranlukast Intermediate（CAS:30131-16-9）
Pranlukast Intermediate（CAS:13633-25-5）
Cilostazol Intermediate（CAS:73963-42-5）
Cilostazol Intermediate（CAS:54197-66-9）
Tosufloxacin Intermediate（CAS:103831-11-4）
Tosufloxacin Intermediate（CAS:100491-29-0）
Pyronaridine Intermediate （CAS:6626-40-0）
Pyronaridine intermediate (CAS:85236-51-7)
ABOUT US
Yuanshu Pharmaceutical Technology Co.,Ltd. was established in 2015 in Nanjing ( Life Science and Technology Innovation Park ), which focus on medicines and fine electronic chemicals field , and be entitled as ' Jiangsu Good Enterprise ', awarded ISO 9001 certification in 2017, besides, as a ' National High Technology Enterprise ’honour in year 2018.Yuanshu was listed on the Science and Technology Innovation Board of Jiangsu Equity Trading Center in year 2020.
Yuanshu Pharmaceutical Technology Co., Ltd. has a modern R&D center in Jiangsu Life Science and Technology Innovation Park. We have international advanced equipments, management system and functional departments. Yuanshu focuses on the CRO and CDMO of clinical drug intermediates with high synthesis difficulty, and the development of ADC drug. The R&D has a professional process development team and follows strict confidentiality system and intellectual property protection system for customized projects. Till June 2021, 15 patents have been authorized and 11 patents have been accepted.
The concept of our company is to adhere to scientific and technological innovation is the source power of enterprise development! We will strive to become a professional manufacturer and supplier in the field of medicines and materials.
Basic Information
Tax ID
91320113MA1MAEFT4E
Country/Region
Jiangsu, China
Year Established
2015
Registered Capital
CNY 5 Million
Business Type
CRO
Total Employees
50-100 people
Quality Management Certificate
ISO9001
Total Annual Revenue
-
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
Yuanshu focuses on the CRO and CDMO of clinical drug intermediates with high synthesis difficulty, and the development of ADC drug.
PLANT LOCATION
COMPANY ALBUM
){kind=link}
